Menarini
The Menarini Group is the largest Italian biopharmaceutical company, with a heritage spanning over 130 years, being founded in 1886. The Group operates in more than 100 countries worldwide, but places a strong emphasis on developing local partnerships that create real value for partners and patients.
Menarini Australia sits within Menarini Asia-Pacific, which is well-established across 13 key healthcare markets in the region. This structure provides Menarini Australia with access to the extensive benefits of a large pharmaceutical company, combined with the energy and enthusiasm of a rapidly expanding local business.
Menarini’s vision is to be a leading provider of healthcare products to invigorate the lives of Australian patients and empower them to live healthier and happier.
Menarini is proud to partner with the Cancer Nurses Society of Australia to support Sosido, a secure online knowledge-sharing and Q&A platform that connects cancer nurses across Australia. By supporting Sosido, Menarini recognises the critical role nurses play in advancing cancer care through leadership, education, and research. This partnership reflects a shared commitment to:
- Fostering connectivity among cancer nurses, especially those in regional and remote areas
- Encouraging nurse-led research, by amplifying visibility of publications and projects
- Promoting continual professional development through real-time knowledge exchange
Beyond Sosido, Menarini is also supporting cancer nurses through several key initiatives, including:
Ensuring optimal patient experience for those undergoing IV Iron Infusions
Providing resources and education to help nurses confidently administer IV iron and identify and manage infusion-related adverse events
Providing options for the treatment of breakthrough cancer pain
Offering accessible, online education to support safe and effective use of rapid onset-opioids (used for the management of breakthrough cancer pain)
Identifying areas of unmet need in patients with metastatic breast cancer
Menarini's support reinforces the importance of nurse-led care, education, and research in advancing cancer treatment and improving outcomes for patients. Stay tuned—further updates on these initiatives will be shared via Sosido and the CNSA website in the coming months.
For more information regarding Menarini’s Oncology Products, please refer to our website or contact the Medical Information Team:
Telephone: 1800 644 542
Email: [email protected]
Website: www.menarini.com.au/products/prescription-products/